* PATENTS:
-> Products protected by valid patents are not offered for sale in countries where
The sale of such products constitutes a patent infringement and its liablity is at buyer's risk
->Products currently covered by patents are offered only for R&D purpose.
|
Product NO
|
|
Product name
|
CAS No
|
Application
|
|
BBTC-017
|
C
|
Capecitabine
|
154361-50-9/ 158798-73-3
|
API
|
|
BBTF-002
|
F
|
Fluorocytosine
|
2022-85-7
|
Intermediates
|
|
BBTT-008
|
T
|
1,2,3-Triacetyl-5-deoxy-D-ribose
|
62211-93-2
|
Intermediates
|
|
BBTD-015
|
D
|
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine
|
161599-46-8
|
Intermediates
|
|
BBTD-016
|
D
|
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate
|
162204-20-8
|
Intermediates
|
|
BBTD-017
|
D
|
Decitabine
|
2353-33-5
|
API
|
|
BBTT-009
|
T
|
1,3,5-Tri-O-acetyl-2-deoxy-D-erythro-pentofuranose
|
4594-52-9
|
Intermediates
|
|
BBTD-018
|
D
|
2-Deoxy-D-ribose
|
533-67-5
|
Intermediates
|
|
BBTA-012
|
A
|
5-Azacytosine
|
931-86-2
|
Intermediates
|
|
BBTT-010
|
T
|
1,3,5-Tri-O-acetyl-2-deoxy-alpha-D-erythro-pentofuranose
|
96291-74-6
|
Intermediates
|
|
BBTC-019
|
C
|
1-Chloro-3,5-di(4-chlorbenzoyl)-2-deoxy-D-ribose
|
3601-90-9/21740-23-8
|
Intermediates
|
|
BBTC-020
|
C
|
1-Chloro-3,5-di-O-toluoyl-2-deoxy-D-ribofuranose
|
3601-89-6
|
Intermediates
|
|
BBTG-002 |
G |
Gemcitabine Hydrochloride |
12111-03-9 |
API
|
|
BBTG-003 |
G |
Gemcitabine |
95058-81-4 |
Intermediates
|
|
BBTD-055 |
D |
2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate |
143157-22-6 |
Intermediates
|
|
BBTD-056 |
D |
2-Deoxy- 2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate |
12111-01-7 |
Intermediates
|
|
BBTD-057 |
D |
2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate |
122111-11-9 |
Intermediates
|
|
BBTD-058 |
D |
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate |
134790-39-9 |
Intermediates
|
|
BBTE-011 |
E |
Ethyl(3R,S)-2,2-difluoro-3-(2,2-dimethyldioxolan-4-yl)propionate |
95058-92-7 |
Intermediates
|
|
BBTF-008
|
F
|
Fludarabine phosphate
|
75607-67-9
|
API
|
|
BBTF-003
|
F
|
Fludarabine
|
21679-14-1
|
Intermediates
|
|
BBTP-014 |
P |
Paclitaxel |
33069-62-4 |
API
|
|
BBTT-029 |
T |
Temozolomide |
85622-93-1 |
API
|
|
BBTC-040 |
C |
Cyano temozolomide |
114601-31-9 |
Intermediates
|
|
BBTT-030 |
T |
Temozolomide Acid |
113942-30-6 |
Impurity
|
|
BBTC-051 |
C |
Carboplatin |
41575-94-4 |
API |
|
BBTC-052 |
C |
Cisplatin |
15663-27-1 |
API |
|
BBTO-008 |
O |
Oxaliplatin |
61825-94-3 |
API |
|
BBTN-005 |
N |
Nedaplatin |
95734-82-0 |
API |
|
BBTD-068 |
D |
(1R,2R)-(-)-1,2-diaminocyclohexane |
20439-47-8 |
Intermediates |
|
BBTD-069 |
D |
Trans-1,2-diaminocyclohexane |
1121-22-8 |
Intermediates |
|
BBTC-053 |
C |
Cyclobutanecarboxylic acid |
3721-95-7 |
Interemediates |
API and intermediates
+ Antibiotics Agent